يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"PD-1/PDL-1-blockade"', وقت الاستعلام: 0.86s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Could PD-1/PDL1 immune checkpoints be linked to HLA signature?

    المؤلفون: Correale P., Saladino R. E., Nardone V., Giannicola R., Agostino R., Pirtoli L., Caraglia M., Botta C., Tagliaferri P.

    المساهمون: Correale P., Saladino R.E., Nardone V., Giannicola R., Agostino R., Pirtoli L., Caraglia M., Botta C., Tagliaferri P.

    مصطلحات موضوعية: HLA allele, outcome, PD-1/PDL-1-blockade, Antibodies, Monoclon al, B7-H1 Antigen, Biomarker, Drug-Related Side Effects and Adverse Reaction, Programmed Cell Death 1 Receptor

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31865873; info:eu-repo/semantics/altIdentifier/wos/WOS:000508238000001; volume:11; issue:18; firstpage:1523; lastpage:1526; numberofpages:4; journal:IMMUNOTHERAPY; http://hdl.handle.net/10447/513945Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85077158166

    الإتاحة: https://doi.org/10.2217/imt-2019-0160Test
    http://hdl.handle.net/10447/513945Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab

    المؤلفون: Giannicola R., D'arrigo G., Botta C., Agostino R., Del Medico P., Falzea A. C., Barbieri V., Staropoli N., Del Giudice T., Pastina P., Nardone V., Monoriti M., Calabrese G., Tripepi G., Pirtoli L., Tassone P., Tagliaferri P., Correale P.

    المساهمون: Giannicola R., D'arrigo G., Botta C., Agostino R., Del Medico P., Falzea A.C., Barbieri V., Staropoli N., Del Giudice T., Pastina P., Nardone V., Monoriti M., Calabrese G., Tripepi G., Pirtoli L., Tassone P., Tagliaferri P., Correale P.

    مصطلحات موضوعية: Auto-antibodie, IrAE, MNSCLC, PD-1/PDL-1-blockade

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31289683; info:eu-repo/semantics/altIdentifier/wos/WOS:000476767600013; volume:11; issue:1; firstpage:81; lastpage:90; numberofpages:10; journal:MOLECULAR AND CLINICAL ONCOLOGY; http://hdl.handle.net/10447/512790Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85070728555

    الإتاحة: https://doi.org/10.3892/mco.2019.1859Test
    http://hdl.handle.net/10447/512790Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    Could PD-1/PDL1 immune checkpoints be linked to HLA signature?

    المؤلفون: Valerio Nardone, Rita Emilena Saladino, Pierosandro Tagliaferri, Rita Agostino, Luigi Pirtoli, Rocco Giannicola, Ciro Botta, Michele Caraglia, Pierpaolo Correale

    المساهمون: Correale P., Saladino R.E., Nardone V., Giannicola R., Agostino R., Pirtoli L., Caraglia M., Botta C., Tagliaferri P., Correale, P., Saladino, R. E., Nardone, V., Giannicola, R., Agostino, R., Pirtoli, L., Caraglia, M., Botta, C., Tagliaferri, P.

    المصدر: Immunotherapy. 11:1523-1526

    مصطلحات موضوعية: Drug-Related Side Effects and Adverse Reactions, Programmed Cell Death 1 Receptor, Immunology, Antibodies, Monoclon al, Human leukocyte antigen, B7-H1 Antigen, Immune system, HLA Antigens, irAE, Neoplasms, Humans, Immunology and Allergy, Medicine, PD-1/PDL-1-blockade, business.industry, Antibodies, Monoclonal, Biomarker, Signature (logic), Haplotypes, Oncology, outcome, Immunotherapy, HLA allele, Drug-Related Side Effects and Adverse Reaction, business, Biomarkers

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c70213e3b3eb8b72144bf5a6bb289900Test
    https://doi.org/10.2217/imt-2019-0160Test


    أضف إلى المفضلة
  4. 4
    Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab

    المؤلفون: Antonia Consuelo Falzea, Valerio Nardone, Rocco Giannicola, Vito Barbieri, Nicoletta Staropoli, Graziella Calabrese, Graziella D'Arrigo, Marika Monoriti, Cirino Botta, Pierfrancesco Tassone, Pierosandro Tagliaferri, Pietro Del Medico, Pierpaolo Correale, Giovanni Tripepi, Pierpaolo Pastina, Teresa Del Giudice, Rita Agostino, Luigi Pirtoli

    المساهمون: Giannicola R., D'arrigo G., Botta C., Agostino R., Del Medico P., Falzea A.C., Barbieri V., Staropoli N., Del Giudice T., Pastina P., Nardone V., Monoriti M., Calabrese G., Tripepi G., Pirtoli L., Tassone P., Tagliaferri P., Correale P., Giannicola, R, D'Arrigo, G, Botta, C, Agostino, R, Del Medico, P, Falzea, Ac, Barbieri, V, Staropoli, N, Del Giudice, T, Pastina, P, Nardone, V, Monoriti, M, Calabrese, G, Tripepi, G, Pirtoli, L, Tassone, P, Tagliaferri, P, Correale, P

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, IrAE, Extractable nuclear antigens, medicine.medical_treatment, Salvage therapy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Lung cancer, Adverse effect, MNSCLC, Chemotherapy, Auto-antibodie, PD-1/PDL-1-blockade, business.industry, Hazard ratio, Cancer, Articles, medicine.disease, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, Nivolumab, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ea65fae89e1e2a8e0f0281ab68e9397Test
    http://hdl.handle.net/10447/512790Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث